Tyler Pugsley

📣 📣 📣 Through this partnership, COTA makes our hematologic oncology data available through Panalgo's Instant Health Data Analytics (IHD) platform. The collaboration will initially focus on COTA's hematologic oncology data, with plans to add solid tumor data in the future. The partnership also includes research collaborations and AI/technology co-development opportunities. At COTA, we are known for having the highest quality and most complete oncology RWD from electronic health records (EHRs) sourced from a 50/50 split of academic and community care settings across the U.S. Our data contain complete and concise longitudinal patient journeys that support regulatory submissions and help to answer research questions involving treatment patterns, real-world outcomes, care comparisons, and more. Read the full announcement ➡ link in comments ⬇ #realworlddata #rwd #realworldevidence #rwe #oncologyresearch #pharma

50

2 Comments

Our CEO, Jim Nasr, shares insights on the importance of working with AI experts who understand the context of healthcare, especially in cancer research. In this clip from our recent podcast with Devico Solutions, Jim discusses how merging public data with private and semi-private clinical data can accelerate treatment options, drive new drug discoveries, and ultimately save lives. A big thank you to Devico Solutions for having us on your podcast! Watch the clip to learn more about how AI is improving healthcare: #AIinHealthcare #CancerResearch #HealthTech #DataPrivacy #ClinicalTrials #DrugDiscovery

19

1 Comment

Envision Reimbursement Pathways for AI-Enabled Devices & Compelling Payer Engagement, While Continuously Optimizing Strategies to Meet Evolving Payer Policies & Influence Positive Coverage Determinations! Time is running out to register! All your peers are attending, are you? Learn More: https://bit.ly/4b9n34o

1

Conferences rarely move the needle on strategy overnight. For the Science Center, events like HLTH 2024 are just one chapter in a much larger narrative. Here's how the networking, visibility, and fresh perspectives gained from #HLTH fit into our broader plan: https://lnkd.in/ejy_h7hv

7

1 Comment

Hear from Ray Carlburg, Associate Director of #DataManagement at Poseida Therapeutics, Inc., on how the flexibility of the Zelta platform empowered his team to build studies in-house -- giving them greater control over resourcing and #clinicaltrial timelines, eliminating communication challenges, and saving significant time and money that would otherwise be spent on expensive, time-consuming vendors. Learn more about how Zelta is helping biotech and pharma companies like Poseida to accelerate their clinical trials with control and confidence. https://lnkd.in/eJ9z8PSN

40

As more pharma companies leverage AI, what are the most promising use cases? Hear from several industry leaders including COTA CEO Miruna Sasu in this article by Meagan Parrish from PharmaVoice. Miruna shares ways AI can improve our understanding of disease progression and outcomes throughout the patient journey. She notes how the increase of accessible genomic data plus accelerated data processing capabilities will allow us to take a more proactive approach to cancer care. #realworlddata #realworldevidence #pharma #healthcareAI #oncologyresearch https://lnkd.in/eBYA3NvY

21

Effectively bridging the gap between healthcare provider (HCP) and direct-to-consumer (DTC) marketing silos is critical for advancing cohesive virtual care strategies. This article dives into tactics for aligning these traditionally separate channels, emphasizing the importance of integrated data insights to personalize messaging across all patient touchpoints. By breaking down these silos, healthcare organizations can offer a seamless, patient-centered experience that boosts engagement, adherence, and health outcomes. Explore the full article here for insights into building a unified approach: https://lnkd.in/eEy2yvQ2 Discover about how we're transforming virtual care: https://lnkd.in/e5swhDbQ 

3

🚀 Enhancing #pharma drugs with health software: come learn about the FDA's PDURS Framework and how we can help navigate it on July 9th! 💊📱 💡 The FDA’s Prescription Drug Use-Related Software (#PDURS) framework is a true game-changer in the pharmaceutical industry. This innovative approach allows #pharma manufacturers to include software in a drug label, provided it demonstrates added clinical benefits. 💊📱By integrating digitally-delivered interventions together with pharmaceutical treatments, we can significantly improve health outcomes for a wide range of diseases. This strategy not only impacts health outcomes and could boost patient and healthcare provider experiences, but also enhances brand differentiation and extends lifetime value. 👉 Join pharmaphorum's expert webinar, moderated by Jonah Comstock and featuring EVERSANA's SME Marty Culjat and Edward Cox, Head and General Manager of Digital Health and Medicines at Pfizer, to delve deeper into this transformative approach. Don't miss out on this opportunity to stay ahead in the ever-evolving pharma and health innovation landscape! 🗓 Register here: https://lnkd.in/dHB6XwXT #PharmaInnovation #HealthTech #PDURS #FDA #healthinnovation #MDSW #DMD

12

📢 Upcoming CRAACO Webinar: Clinical Research as a Care Option with Modern Software 🗓 Mark your calendars for November 14th! In this exclusive webinar, our industry experts will discuss how cutting-edge software is transforming clinical research into a seamless extension of patient care. Discover how ObjectiveHealth, a 35-site network, is embedding clinical trials directly into patient care using innovative, AI-driven technology. We’ll also dive into how RealTime’s Devana platform is helping optimize site performance and connect clinical operations with front-line care providers. What You’ll Learn: -How to match the right trials with the right sites -Access real-time insights into trial performance across a growing network -Connect clinical operations teams with physicians to streamline trial execution This is a must-attend for professionals in the academic medical research space, healthcare providers, and anyone in pharma looking to integrate clinical research into patient care. 🔗 Register now and save your spot! https://lnkd.in/gNTn7EGE #ClinicalResearch #PatientCare #AIinHealthcare #ClinicalTrials #Devana #HealthcareInnovation #ResearchAndCare

7

1 Comment

In a recent article highlighting 2025 predictions for #clinicalresearch, Lindus Health co-founder Michael Young discusses how #hybridclinicaltrials will be utilized more and more with the help of tools like #AI. Read the full article: https://lnkd.in/evaXAbf3 #patientexperience #clinicaltrials #cro

25

Looking to implement AI in your clinical trials? Our AI Luminaries can guide you on leveraging cutting-edge technologies to streamline trial operations and data analysis. Brian Martin, Angela Radcliffe, Jonathan Crowther, Micah Lieberman  #AI #ClinicalTrials *Only registered members can ask questions. Not registered yet? Join the ClinEco community today - it's free and simple!

12

We all know about the benefits of RWD and clinical trial data: one category complements the other, while each individually offers distinct insights to providers, payers, and sponsors. But do we know enough about the unique challenges life science companies face when trying to integrate RWD data with their own trial data for a more holistic understanding of investigational therapies and the multiple use cases they may serve? Through our proprietary data centres in France and elsewhere and our sovereign cloud solution, Cegedim Health Data offers an answer to one of the main data integration constraints for pharma companies – the issue of data access and storage. Gilles Paubert, Global Head of Cegedim Health Data #realworlddata #rwd #realworldevidence #rwe

2

Transforming Pediatric Oncology: The Power of Informatics 💡 Mike Gurley outlines a goal to use informatics in clinical development, cutting through the opacity of clinical workflows. Collaborating with Kids in Focus on tumor board software, the aim is to normalize patient charts, aligning data with ontologies. 📊🧬 This partnership enhances data clarity for better decision-making in pediatric cancer care, improving treatment outcomes. 🌟 💡 Click the link in our bio for more stories on wellness! #TransformWellnessTogether #AIWellness #healthcare #healthandwellness #PediatricCancer #InformaticsInnovation #DataDrivenCare #HealthTech

3

What milestones should Medtech companies prioritize to achieve a successful exit? Susan Stimson, Managing Director at KCK Medtech, highlights the importance of strategic planning for reimbursement. She emphasizes that companies must go beyond securing a billing code and address the more complex issue of coverage, which requires aligning clinical data with payer policies. Proactively tailoring clinical trials to meet payer expectations is critical. Small adjustments, such as including specific criteria that align with reimbursement policies, can strengthen a company’s case. While these changes don’t guarantee coverage, they significantly enhance the likelihood of success. Stimson underscores the value of integrating payer considerations into trial design early, ensuring smoother market access and reimbursement outcomes. Tune into the full panel, “Medtech Growth Capital: What is the New Normal in Late-Stage Financing?” where our panelists explored the current Medtech investment landscape, focusing on growth-stage financing, reimbursement strategies, and pathways to exit, including M&A and IPOs. Featured Panelists: • Carly Roddy — J.P. Morgan • Susan Stimson — KCK Medtech • Alexander Schmitz — Endeavour Vision • Kyle Dempsey, MD, MBA — MVM Partners • Anthony Williams — HealthQuest Capital As we look back at highlights from LSI USA '24, we're gearing up for LSI USA '25 this March 17-21. Apply on our website today to join top Medtech and Healthtech leaders in Dana Point, California.

17

1 Comment

During our recent webinar on the biggest challenges facing clinical trial operations, we learned that 50% of attendees viewed "lack of data recency" as the biggest barrier to utilizing data to improve trial strategies. Watch the webinar on-demand at this link: https://hubs.la/Q02WNTqq0

8